England is currently under the third national lockdown since the outbreak of the Covid-19 pandemic in the country. To bring life back to normal, countries like Britain, China, Germany, Russia and the U.S have been racing against time to roll out coronavirus vaccines.

TOP INSIGHT
England is currently under the third national lockdown since the outbreak of the Covid-19 pandemic in the country. To bring life back to normal, countries such as Britain, China, Germany, Russia and the United States have been racing against time to roll out coronavirus vaccines.
The study will be carried out by a partnership between the Imperial College London, the Royal Free London NHS Foundation Trust and the clinical company hVIVO.
Researchers are encouraging people aged between 18 and 30 years old, who are at the lowest risk of complications resulting from the novel coronavirus, to consider volunteering to take part.
The initial study will aim to establish the least amount of virus needed to cause Covid-19 infection. As there is much less information available about new virus variants, the doctors will use the original virus that has been circulating in Britain since March 2020.
Once the initial study has taken place, vaccine candidates, which have proven to be safe in clinical trials, could be given to small numbers of volunteers who are then exposed to Covid-19, helping to identify the most effective vaccines and accelerate their development, according to the college.
"We expect these studies to offer unique insights into how the virus works and help us understand which promising vaccines offer the best chance of preventing the infection," said Dix.
To bring life back to normal, countries such as Britain, China, Germany, Russia and the United States have been racing against time to roll out coronavirus vaccines.
Source-IANS
MEDINDIA




Email










